MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. (ANVS)
source: myfinsight.com
Download
Download image
Proceeds from issuance of
common stock, and...
$3,698,367
Net cash provided by
financing activities
$3,698,367
Net (decrease)
increase in cash and cash...
-$5,313,257
Canceled cashflow
$3,698,367
Accrued expenses
$6,470,118
Accounts payable
$2,685,152
Stock-based compensation
expense
$182,823
Net cash used in
operating activities
-$9,011,624
Canceled cashflow
$9,338,093
Net loss
-$17,606,382
Prepaid expenses and
other current assets
$475,335
Change in fair value of
warrants
-$268,000
Back